Just a little weekend thought for all those investors losing faith in this company due to the share price - don't let the tail wag the dog.
OCC reported interest on its cash holdings alone of $850K:
Take a step back. That investors are selling a company that has $25 million in cash, is growing revenues (running at last reported $2.6 million yearly revenue rate) at 31.5% and forecast to go cash flow positive in CY 2025, well before that cash buffer gets pressed, for a mere $70 million, is frankly bonkers.
That's purely on early global BioHorizons/Henry Schein Striate and Australian Remplir sales. Let alone going global on Remplir, following with CelGro tendon and rope, ACI, which turned Vericel in the US to a $1.6 billion mkt cap company, and of course about to report in days (at long bloody last) surgery vs ATI results, in an almost tandem study it did with a cortisone vs ATI study with Johnston and Johnston (even if you put a J&J partnership probability at 10% you'd surely double this mkt cap).
On existing business alone, OCC just announced a $645K sales quarter - that's a $2,580 million per year sales run rate in the last quarter. I would put 2024FY sales way above that and Veritas put their sales for 2024FY (BEFORE THIS EXCELLENT SALES RESULT) at $4.6 million (Veritas admittedly need to a little work on their recognition of the contract revenue for some objectivity and warning for investors using it as a tool).
I might die skint holding OCC in 20 years time. I think more likely I will own a small piece of a company that will have at least progressed to posting yearly revenues in the 100's of millions, possibly quarterly. Its no Amgen for the dreamers, but its ridiculous value at $70mill on existing known fundamentals and Thursday I bought more.
- Forums
- ASX - By Stock
- OCC
- Ann: Appendix 4E & Annual Report
Ann: Appendix 4E & Annual Report, page-17
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 38.5¢ | $17.64K | 45.67K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 23269 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 25000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 23269 | 0.385 |
4 | 20914 | 0.380 |
5 | 81340 | 0.375 |
10 | 112676 | 0.370 |
4 | 80622 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 25000 | 2 |
0.400 | 290626 | 12 |
0.405 | 65143 | 3 |
0.410 | 157677 | 7 |
0.415 | 3200 | 1 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online